scholarly journals In Reply to the Discovery Trial Report Evaluating the Potential Benefit of Hydroxychloroquine, Lopinavir and Ritonavir with and Without Interferon Β-1a in Hospitalized Covid-19 Patients

2021 ◽  
Vol 05 (03) ◽  
Author(s):  
Valere Lounnas ◽  
Xavier Azalbert ◽  
Christian Perronne
2004 ◽  
Vol 31 (S 1) ◽  
Author(s):  
A Kahmann ◽  
A Metzner ◽  
T Fangerau ◽  
S Kotterba ◽  
E Sindern
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document